Mesenchymal stromal cells inhibit CD25 expression via the mTOR pathway to potentiate T-cell suppression

scientific article published on 23 February 2017

Mesenchymal stromal cells inhibit CD25 expression via the mTOR pathway to potentiate T-cell suppression is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/CDDIS.2017.45
P932PMC publication ID5386489
P698PubMed publication ID28230853

P2093author name stringHyun-Ja Lim
Kwangmin Na
Myung-Shin Jeon
Sun U Song
TacGhee Yi
Hyun Seung Yoo
Kyuheon Lee
Yong Xu Zhang
P2860cites workIdentification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myelomaQ24600346
Update on mesenchymal stem cell-based therapy in lupus and sclerodermaQ26777402
Selection of induction therapy in kidney transplantationQ26864234
Immunobiology of mesenchymal stem cellsQ27004487
Mesenchymal stem cells in health and diseaseQ29614296
Molecular mechanisms of mTOR-mediated translational controlQ29615529
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cellsQ29618766
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuliQ29618769
Marrow stromal cells as stem cells for nonhematopoietic tissuesQ29618770
Mesenchymal stem cellsQ29619804
mTOR signaling at a glanceQ29619857
Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent mannerQ33438830
Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitusQ33719419
Immunoregulatory functions of mTOR inhibition.Q33761278
Interleukin-2 (IL-2) regulates the accessibility of the IL-2-responsive enhancer in the IL-2 receptor alpha gene to transcription factorsQ33957692
Mesenchymal Stromal Cells Disrupt mTOR-Signaling and Aerobic Glycolysis During T-Cell ActivationQ50700830
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.Q50767537
Murine Mesenchymal Stem Cells Suppress T Lymphocyte Activation Through IL-2 Receptor α (CD25) Cleavage by Producing Matrix MetalloproteinasesQ53287592
Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells.Q53476120
The interleukin-2 T-cell system: a new cell growth model.Q55062562
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric OxideQ61645540
Effect of rapamycin on the expression of the IL-2 receptor (CD25)Q70909270
Nuclear Mutants of Maize with Defects in Chloroplast Polysome Assembly Have Altered Chloroplast RNA MetabolismQ77071058
Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complexQ78833880
Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cellsQ80415050
Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in ratsQ82730941
Bone marrow-derived clonal mesenchymal stem cells inhibit ovalbumin-induced atopic dermatitisQ34007793
Mesenchymal Stem Cell Lines Isolated by Different Isolation Methods Show Variations in the Regulation of Graft-versus-host DiseaseQ34979429
Mesenchymal stem cells in multiple sclerosis - translation to clinical trialsQ35422678
The liver kinase B1 is a central regulator of T cell development, activation, and metabolismQ35500559
Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys?Q35559514
Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patientsQ35669073
Regulation and function of mTOR signalling in T cell fate decisionsQ36157753
Both integrated and differential regulation of components of the IL-2/IL-2 receptor systemQ36566986
mTOR at the crossroads of T cell proliferation and toleranceQ36769225
The mammalian target of rapamycin: linking T cell differentiation, function, and metabolismQ37792556
Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis.Q37979498
Multipotent mesenchymal stromal cells and the innate immune systemQ38005275
Translational control of immune responses: from transcripts to translatomesQ38212816
Interleukin 2: the molecule and its functionQ38257586
Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implicationsQ38261365
Targeting the translation machinery in cancerQ38368049
Characterization of mouse clonal mesenchymal stem cell lines established by subfractionation culturing methodQ38469531
IRE1-dependent activation of AMPK in response to nitric oxideQ38960360
Treatment of severe steroid-refractory graft-versus-host disease with IL-2R alpha chain (CD25) monoclonal antibodyQ39393701
Interleukin-2: inception, impact, and implicationsQ39603037
Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.Q39698715
Clinical Trial of Human Umbilical Cord Blood-Derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa StudiesQ39713357
ATF4-mediated induction of 4E-BP1 contributes to pancreatic beta cell survival under endoplasmic reticulum stressQ40006517
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivoQ40662801
The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivoQ41530637
Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9Q42276892
Reactive nitrogen species induced by hyperglycemia suppresses Akt signaling and triggers apoptosis by upregulating phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) in an LKB1-dependent mannerQ42518946
Polysome fractionation and analysis of mammalian translatomes on a genome-wide scaleQ42738454
Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.Q44044488
Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-vs-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletionQ44636594
Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytesQ45024308
Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.Q45959326
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue2
P304page(s)e2632
P577publication date2017-02-23
P1433published inCell Death and DiseaseQ2197222
P1476titleMesenchymal stromal cells inhibit CD25 expression via the mTOR pathway to potentiate T-cell suppression
P478volume8

Reverse relations

cites work (P2860)
Q92063575Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis
Q42030296Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype
Q49460237Loss of A20 in BM-MSCs regulates the Th17/Treg balance in Rheumatoid Arthritis

Search more.